Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Third Quarter 2022 Financial Results and Provide Corporate Update
02 November 2022 - 7:01AM
Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused
biopharmaceutical company, today announced it will report its third
quarter 2022 financial and operating results after the close of
U.S. financial markets on Tuesday, November 8, 2022.
Conference
Call/Webcast Information: |
|
|
Date: |
Tuesday, November 8, 2022 |
|
|
Time: |
4:30 pm Eastern Time (1:30 pm
Pacific Time) |
|
|
Listen-Only Audio
Webcast: |
https://edge.media-server.com/mmc/p/s4tct434 |
|
|
Live Call Participant: |
Registration Link |
To participate in the live call, please register using the
following link (also noted above) to receive dial-in details and a
unique PIN code: Register and receive dial-in details. The audio
webcast will also be broadcast live on the “Investors” section of
Xenon's website at investor.xenon-pharma.com and posted for replay
following the event. The above-listed dates and times are subject
to change.
About Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals (NASDAQ:XENE) is a
clinical stage biopharmaceutical company committed to developing
innovative therapeutics to improve the lives of patients with
neurological disorders. We are advancing a novel product pipeline
of neurology therapies to address areas of high unmet medical need,
with a focus on epilepsy. For more information, please visit
www.xenon-pharma.com.
“Xenon” and the Xenon logo are registered
trademarks or trademarks of Xenon Pharmaceuticals Inc. in various
jurisdictions. All other trademarks belong to their respective
owner.
Investor/Media Contact:Jodi RegtsXenon
Pharmaceuticals Inc.Phone: 604.484.3353Email:
investors@xenon-pharma.com
Xenon Pharmaceuticals (NASDAQ:XENE)
Historical Stock Chart
From Mar 2024 to Apr 2024
Xenon Pharmaceuticals (NASDAQ:XENE)
Historical Stock Chart
From Apr 2023 to Apr 2024